Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Bioptix Inc (NASDAQ:BIOP)

3.37
Delayed Data
As of Mar 24
 +0.04 / +1.20%
Today’s Change
2.14
Today|||52-Week Range
6.65
-12.24%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$15.2M

Company Description

BiOptix, Inc. is a vitro diagnostic company. The company focuses on the commercializing of its blood-based test to serve as an adjunctive test in the diagnosis and treatment of acute appendicitis in children adolescent and young adult patients. The company was founded on July 24, 2000 and is headquartered in Boulder, CO.

Contact Information

BiOptix, Inc.
1775 38th Street
Boulder Colorado 80301
P:(303) 545-5550
Investor Relations:

Employees

Shareholders

Individual stakeholders3.75%
Other institutional3.64%
Mutual fund holders1.63%

Top Executives

Stephen T. LundyPresident, Chief Executive Officer & Director
Jeffrey G. McGonegalChief Financial Officer & Secretary
Richard WhitcombSenior Vice President-Corporate Development